Steven Staben
Chief Scientific Officer, 10% Owner · Lycia Therapeutics, Inc.
Individual
- 2026
- Oct 26, 2026
- 1
Filings (90d)
Other insiders active in the same stocks
Insiders who reported open-market trades in the last 12 months at the companies Steven Staben files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- Venrock Healthcare Capital Partners III, L.P. - $38.30M in LYCA purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is Steven Staben?
Steven Staben is a corporate insider, tracked as Chief Scientific Officer, 10% Owner of Lycia Therapeutics, Inc. (LYCA). InsiderAlpha holds 1 primary Form 4 filing for them, the earliest from 2026, updated as new SEC EDGAR filings are processed.
How many SEC Form 4 filings has Steven Staben submitted recently?
1 primary Form 4 filing in the last 90 days, covering 1 company.